ASX:TLXBiotechs
Does Telix Offer Opportunity After Regulatory Update and Recent 7% Jump in 2025?
Thinking about what to do with Telix Pharmaceuticals stock? You are not alone. There is a lot to consider here, whether you already hold ASX:TLX or are simply weighing a new position. Over the past year, the stock has given investors some volatility, dropping around 8.5%. However, when you look at a three-year period, the performance shows a notable improvement, with returns rising above 180%. This combination of recent swings and longer-term growth leaves investors debating whether the stock...